Play 4200+ Free Online Slots

Play for Fun

Your guide to online casino

SlotMarks.com

Best Online Casinos for 2019

Top casinos
Health Health Care Others

Luven Diagnostic

Ended
Ended: Feb 28, 2018

Cancer Diagnostic Technology

Unique cancer diagnostic technology

Unique cancer diagnostic technology designed to save millions of lives. The Luven technology allows to detect the disease in its early stages, thus, preventing its progression in thousands of patients.

The LUVEN screening test method created by the scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy.

Promoting a unique cancer diagnosis technology.

Website

luvenmed.io

Not Verified

How to verify ICO?

Share this ICO

Intro Video

ICO Details

Ticker Symbol:
LVN
Platform
Ethereum (ERC20)
Accepts:
ETH, BTC
Hard Cap:
30,000,000 LVN
Country:
Ukraine
Total supply
39,000,000 LVN

Public Crowdsale

Ended
Date Sale:
Dec 8, 2017 — Feb 28, 2018 @ 82 days
Sale Avalable Tokens:
30,000,000 LVN @ 76.9%

Token distribution

TEAM REMUNERATION 7.0%
>= 3,000 ETH: 4.0%
CLINICAL TRIALS 50.0%
MARKETING 25.0%
1st week of ICO: 10.0%
3d week: 15.0%
1-st Day: 30.0%
2nd week: 20.0%
>= 100 ETH: 2.0%
LEGAL COMPONENT 10.0%
>= 1,000 ETH: 3.0%
BOUNTY CAMPAIGN 3.0%
1-st week: 25.0%
>= 3 ETH: 1.0%
>= 5,000 ETH: 5.0%
SOFTWARE 15.0%

ICO Overview

The LUVEN screening test method created by scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy. The LUVEN technology allows diagnosing the disease at its early stages , thus, giving a chance to thousands of people to prevent its further development.

About Luven Diagnostic The LUVEN screening test method created by scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy. The LUVEN technology allows to diagnose the disease at its early stages, thus, giving a chance to thousands of people to prevent its further development. For more than 20 years the Ukrainian scientists have been developing a diagnostic method based on cyto-morphological and cyto-biophysical properties of the buccal epithelial cells. In 2004 at Fenix Cancer Research Center, they continued their research and, finally, came up and implemented an experimental method. A new method of biomaterial analysis allowed to establish a cancer diagnosis at its early stages and to assess predisposition to cancer. A great success in this medical field opened a door to new possibilities,including cancer prevention and therapy. The longstanding scientific research in this field culminated in development of The Luven diagnostic system. Why is it critical to detect cancer in its early stage? Around 10 mln people worldwide are annually diagnosed with cancer, with every third patient dying from it. One of the main reasons of such a high mortality rate is late diagnosis. According to statistics: after treatment in stage 1 cancer — around 93% of patients survive; stage 2 cancer — around 75% survive; stage 3 cancer — 55% survive; stage 4 cancer — only 13% survive; This is why one should get a check-up as often as possible, thus preventing the disease progression. Regardless of the rapid development of modern medicine and biology cancer, annually, takes millions of human lives. One cancer patient, worldwide, dies from this disease every 30 seconds. The key to successful cancer treatment is early diagnosis. Our History The development of this method started in early 1983 at the research institute, chair for genetics. Based on the cellular theory by Rudolf Vichow, a team of scientists was working on a diagnostic method and studying buccal cells. Ms. Galina Shchukina, a genetic scientist and cytologist, was at the head of the scientific research. She conducted an in-depth study of scientific papers describing a new biophysical concept of the gene activity regulation based on the role of relationship between homologous chromosomes and genome. Together with Mr. Alexander Shchukin, a nuclear physicist, they invented an ion trap allowing to estimate bioelectric charge of cells. Further research and studies of this concept laid the basis for a new diagnostic method born in 2004, according to which any changes in the human body reflect on cells, including buccal epithelial cells. It was the first milestone in the development of LUVEN a unique diagnostic and treatment system. As of today, this method allowed to collect statistical data on tests of more than twenty thousand of patients. Why is it lucrative? Cancer research is an acute social problem, in view of this they cast a veil on profits of medical companies. However, in-vitro diagnostics, and particularly cancer diagnostics, is a huge and most rapidly developing sector, with the potential global market of DNA cancer tests worth about $20 bn. Unlike the majority of projects involving ICO, our company has already completed 90% of the whole thing. The presale period starts on November 15 until December 6, 2017. The token sale is planned from January 15 to February 28, 2018.

Telegram members

Hype ICO Stats

Team

Alexander Danilchenk...
CEO
Yana Ivchenko
PR Manager
Nikolay Shchukin
Postgraduate Student of Chair for Biomedical Engineering
Alexander Kamensky
Principal Software Engineer
Grigory Evglevskiy
CTO
Alexander Danilchenko
CEO
Aleksander Shchukin
Nuclear Physician
Lina Lisitsa
SMO/SMM Manager
Galina Shchukina
Geneticist & Cytologist

How to verify ICO

To get a verified status, you need to place a our logo with the link on your ICO's website and make an announcement of the listing in your social network accounts.

Have you found any errors or inaccuracies? Please, let us know . Are you the representative of the ICO? We a variety of offers for cooperation.

Other Interesting ICOs

Ongoing
Demblock

demblock-tge.com

The DemBlock marketplace is an already fully functioning and working decentralized electronic marketplace with the possibility to offer notarized supplier...

Ongoing
HYGH

hygh.tech

The Future Of AdvertisingHYGH is a game-changing peer-to-peer advertising network and content management system, which is set to revolutionise the $600bn...

Ongoing
Filmgrid

filmgrid.space

Filmgrid is a blockchain platform for commerce, streaming and financing of independent films and series over the internet. Of decentralized nature, removes...

Ongoing
Crowd Machine

crowdmachine.com

Crowd Machine is powering the next generation of decentralized blockchain applications. Crowd Machine is creating the Crowd Computer, a decentralized app...

TBA
ArcadierX

arcadierx.io

ArcadierX will utilize the power of distributed ledger technology along with innovations in inventory sourcing and distribution, a platform of trust,...

Ongoing
RMC

rmc.one

Single ecosystem for scholars, producers of mining devices, data centers and miners community RMC – a project which brings together two ideas: а) issuance...

Ongoing
BackCoin

back-coin.com

BackCoin offers to use cryptocurrencies as "gold", which you can always lay and get Fiat money to solve their daily problems, which will not lose possible...

Ongoing
Forest Coin

forestcoin.space

Firstly, we are a social enterprise to reforest and living with nature. Secondly, crowd planting application, everyone can plant tree anywhere in the world....